Intriguingly, we show that whole-body Mfsd2b KO mice and Mfsd2b-specific deletion in platelets exhibit reduced venous thrombosis, whereas Mfsd2b expression in erythrocytes is dispensable for this process. This evidence concerns the gene MFSD2B and deep vein thrombosis.